{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:03:28Z","timestamp":1780067008411,"version":"3.54.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T00:00:00Z","timestamp":1454371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT080782MF"],"award-info":[{"award-number":["WT080782MF"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.neuroscience.2016.01.034","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T15:42:30Z","timestamp":1453477350000},"page":"116-122","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The role of TWEAK\/Fn14 signaling in the MPTP-model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"319","author":[{"given":"S.","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Burkly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-9718","authenticated-orcid":false,"given":"M.","family":"Schwaninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Teismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2016.01.034_b0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0010","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1093\/brain\/aws193","article-title":"Late-onset Parkinsonism in NFkappaB\/c-Rel-deficient mice","volume":"135","author":"Baiguera","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","article-title":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease","volume":"172","author":"Boka","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/bj20021730","article-title":"The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation","volume":"371","author":"Brown","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0025","doi-asserted-by":"crossref","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","article-title":"TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis","volume":"272","author":"Chicheportiche","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0030","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/mol.63.4.784","article-title":"Nuclear translocation of nuclear transcription factor-kappa B by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors leads to transcription of p53 and cell death in dopaminergic neurons","volume":"63","author":"de Erausquin","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","article-title":"Protection by pioglitazone in the MPTP model of Parkinson\u2019s disease correlates with IkappaBalpha induction and block of NFkappaB and iNOS activation","volume":"88","author":"Dehmer","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2005.06.005","article-title":"Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis","volume":"117","author":"Desplat-Jego","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0045","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1471-4159.2004.02399.x","article-title":"Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum","volume":"89","author":"Ferger","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0050","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1038\/sj.emboj.7601441","article-title":"TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration","volume":"25","author":"Girgenrath","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0055","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/jcbfm.2009.280","article-title":"The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain","volume":"30","author":"Haile","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F","article-title":"Dopaminergic neurons degenerate by apoptosis in Parkinson\u2019s disease","volume":"14","author":"Hirsch","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0065","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0070","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"Fc\u03b5RII\/CD23 is expressed in Parkinson\u2019s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells","volume":"19","author":"Hunot","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2008.08.005","article-title":"Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke","volume":"275","author":"Inta","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0085","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1172\/JCI23486","article-title":"TWEAK induces liver progenitor cell proliferation","volume":"115","author":"Jakubowski","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0090","first-page":"713517","article-title":"Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2019s disease","volume":"2011","author":"Litteljohn","year":"2010","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0100","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1523\/JNEUROSCI.3040-07.2008","article-title":"Neurodegeneration and motor dysfunction in a conditional model of Parkinson\u2019s disease","volume":"28","author":"Nuber","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0105","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1523\/JNEUROSCI.3382-05.2005","article-title":"Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation","volume":"25","author":"Polavarapu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0110","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1523\/JNEUROSCI.1089-04.2004","article-title":"Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration","volume":"24","author":"Potrovita","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/35009130","article-title":"Role of NF-kappaB in p53-mediated programmed cell death","volume":"404","author":"Ryan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1098-1136(200010)32:1<102::AID-GLIA100>3.0.CO;2-U","article-title":"TWEAK stimulation of astrocytes and the proinflammatory consequences","volume":"32","author":"Saas","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0125","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/aws250","article-title":"S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway","volume":"135","author":"Sathe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0130","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U","article-title":"TWEAK can induce cell death via endogenous TNF and TNF receptor 1","volume":"29","author":"Schneider","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0135","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson\u2019s disease","volume":"16","author":"Sriram","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0140","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-004-0944-0","article-title":"Cellular pathology of Parkinson\u2019s disease: astrocytes, microglia and inflammation","volume":"318","author":"Teismann","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0150","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson\u2019s disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0155","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1074\/jbc.M409906200","article-title":"The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL\/BCL-W expression","volume":"280","author":"Tran","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0160","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1074-7613(01)00232-1","article-title":"A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis","volume":"15","author":"Wiley","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2488","article-title":"The TWEAK-Fn14 cytokine\u2013receptor axis: discovery, biology and therapeutic targeting","volume":"7","author":"Winkles","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2016.01.034_b0170","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.2741\/2271","article-title":"Tweak and FN14 in central nervous system health and disease","volume":"12","author":"Yepes","year":"2007","journal-title":"Front Biosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:03:18Z","timestamp":1567537398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452216000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":34,"alternative-id":["S0306452216000622"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.034","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}